PSFG
TMO icon

Park Square Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Park Square Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6
Closed -$2.43K – 879
2025
Q2 		$2.43K Hold
6
– – ﹤0.01% 855
2025
Q1 		$2.99K Sell
6
-88
-94% -$47.7K ﹤0.01% 811
2024
Q4 		$48.9K Buy
+94
New +$51.7K 0.03% 272

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Park Square Financial Group's TMO Position: Q3 2025 in Review

Park Square Financial Group sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 6 shares — an estimated $2.43K sold.

Park Square Financial Group first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $48.9K in Q4 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Park Square Financial Group reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Park Square Financial Group sold 6 Thermo Fisher Scientific shares in Q3 2025, an estimated $2.43K.
  • Park Square Financial Group first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • Park Square Financial Group's Thermo Fisher Scientific position peaked at $48.9K in Q4 2024.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Park Square Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.